New Vaccine Introduction ‘MR vaccine introduction in Kenya’

Slides:



Advertisements
Similar presentations
Vaccines related epidemiology Programme design and policy options First EpiTrain course in Advanced Epidemiology Jurmala Latvia Hanna Nohynek.
Advertisements

Global Measles and Rubella Strategic Plan
1 June 2011 Measles update- India Dr. Satish Kumar Gupta Health Specialist UNICEF- India 13 th September 2011.
New Directions in the SightFirst Program, Lions Clubs International Foundation Linda Romano-Derr Regional Program Specialist, South Asia New Directions.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
More proven interventions are available to prevent and treat diarrhea than any other major child killer Jones G Bryce J. et al. Lancet UNICEF. Diarrhoea:
Module 1 Introduction to the polio endgame rationale and IPV vaccine
بسم الله الرحمن الرحيم. IRAN Vaccination policy for post eradication phase Presented by : A. R.ESTEGHAMATI, MD IRAN EPI Manager.
Reproductive and Child Health (R&CH) Presented by: Dr. Mariam J. Bakar & Mr. Yusuph Haji.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
The Cape Verde experience with rubella outbreak & lessons from introducing rubella vaccines MoH Cape Verde ARCI meeting Dar es Salaam, Tanzania Dec 2012.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
Lakeside Public Pool Lifeguard Orientation Review of Red Cross Guidelines.
Proceedings of the SAGE Working Group on Rubella Vaccines Susan E. Reef, MD Global Measles and Rubella Management Meeting March 15, 2011.
Building the Foundations for Better Health Health Services Organization.
Supporting Routine AND Supplementary Immunization Activities in STOP.
Global Health Program Guiding Principles April 2002.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
Departmental Perspectives on Viral Hepatitis
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Working in partnership Countdown for Child Survival in Ethiopia London December 2005 Federal Ministry of Health of the Democratic Republic of Ethiopia.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
NDHS Neonatal Mortality Rate33/1000 live births Infant mortality rate48/1000 live births Under 5 mortality rate61/1000 live births Perinatal Mortality.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
1 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination.
Expanded Program of Immunization Dr. Faten M. Rabie.
IMMUNIZATION IN UGANDA Dan Wamanya IMMUNIZATION IN UGANDA Dan Wamanya USAID/Uganda.
30th anniversary of starting EPI
Immunisation Timeline Milestones in Immunisation 429 BC Thucydides notices smallpox survivors did not get re-infected 900 AD Chinese practise variolation.
Polio Eradication  Although the number of endemic countries is at an all-time low in 2002, the actual number of cases was approximately four times higher.
Edward J. Hoekstra, MD, MSc Edward J. Hoekstra, MD, MSc Senior Health Advisor Senior Health Advisor UNICEF HQ, New York UNICEF HQ, New York Peter Strebel,
Lucile de Comarmond Chief Pharmacist Workshop on Impact of TRIPS/IP on Access to Medicine September 2014.
Update on Measles Mortality Reduction Activities and Linkages with RI.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
LEVELS OF HEALTH CARE VINITA VANDANA.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
MILLENIUM DEVELOPMENT GOALS Board review Notes Dr. Theresita R. Lariosa.
1 |1 | Measles pre-elimination and resurgence in the African region Balcha Masresha IVD AFRO Global Measles Management Meeting Geneva March 2011.
India: Transitioning of Polio Network to Support Other Immunization Activities Jeffrey W McFarland, MD Regional Advisor, WHO South-East Asia Regional Office.
MDG 4 Target: Reduce by two- thirds, between 1990 & 2015, the mortality rate of children under five years.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Primary Health Care Primary Health Care Schemes water and sanitation maternal and child health disease control essential drugs food and nutrition traditional.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Update on Progress toward Measles Situation in EMR September 2008 Dr B. Naouri VPI/DCD/EMRO.
Dr. Waithaka Mwaura.  17 sub-counties  85 wards  495 HFs [ 21% (106) being public ]  175 functional community units  Covers an area of 695 sq km.
Prevention of Vaccine-Preventable Diseases through Information and Education at the California Department of Public Health Vaisali Patel, MPH Candidate.
KEYWORD SHOUT SHOUT A KEYWORD FROM THIS TOPIC PASS THE BALL TO SOMEONE THEY HAVE TO GIVE A DEFINITION - IF CORRECT THEN THEY CAN SIT DOWN AFTER THEY HAVE.
Concepts of Primary health care Ass.Prof:Dr:Essmat Gemaey
Measles Outbreak in Skopje, Republic of Macedonia, 2014 Erjona Shakjiri 1, D. Kochinski 1, Sh. Memeti 1, B. Aleksoski 1, K. Stavridis 1, V. Mikic 1, G.
1 Targeting the intolerable Targeting the intolerable The International Programme on the Elimination of Child Labour.
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Fast-Tracking Treatment to End AIDS ICASA Ambassador Deborah Birx, MD U.S. Global AIDS Coordinator November 30, 2015.
CONSTRAINTS TO PRIMARY HEALTH CARE DELIVERY THE GOVERNMENT OBJECTIVES FOR DELIVERING PHC SERVICES To increase accessibility to quality health care services.
Promoting physical activity for children and young people Schools and colleges Implementing NICE guidance 2009 NICE public health guidance 17.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
A Second Opportunity to Change History What Is Maternal and Neonatal Tetanus? Caused when non-sterile instruments are used to cut the umbilical cord.
Maternal and Neonatal Tetanus Elimination (MNTE) in Kenya Dr Collins Tabu, National Vaccines and Immunization Program Ministry of Health, Kenya.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Seasonal Malaria Chemoprevention: WHO Policy and Perspectives
Progress and Challenges with achieving Universal Immunization Coverage
African Region- priorities to reach the 2020 measles elimination goal.
Key Area 3.7: Immunisation
Maintaining Elimination in an Environment of Persistent Importation
Kenya Pediatric Association Conference,
Ingredients of a Sustainable healthcare SYSTEM– the Cayman islands experience Lizzette Yearwood.
Presentation transcript:

New Vaccine Introduction ‘MR vaccine introduction in Kenya’ Dr Collins Tabu National Vaccines and Immunization Program, Ministry of Health, Kenya

Evolution of the Immunization program Established in 1980 with the main aim of providing immunization against six killer diseases of childhood, before then, provided on an ad- hoc basis through schools and the larger health facilities Therefore concentrated initially on establishing and strengthening the health service delivery Later, targeted Universal Child Immunization goals of immunizing at least 80% of the target population Program focus has since shifted to Disease Elimination and Eradication, with the Goals of: Polio Eradication and Measles, Rubella and Maternal Neonatal Tetanus Elimination Shift with to universal access to immunization with SDGs and Universal Health Coverage as guiding principles

Vaccination strategies Routine immunization serves 80% of population Venues: Clinics, schools, out reach facilities Not a time limited strategy Clients present to receive immunization services Routine Immunization Done in collaboration with other activities Time limited approach Expensive service strategy Useful to reach both hard to reach populations Offer rapid scale up of immunization services. Time limited interventions Very expensive strategy Important for disease control Service is taken to clients National Immunization days Supplementary immunization campaigns 3

UVIS Mission and Vision Vision A Nation free from vaccine preventable diseases. Mission To provide appropriate, accessible, affordable and equitable quality immunization services to the people of Kenya. Mandate To coordinate vaccination services for all vaccine preventable diseases through provision of policy and guidelines and and selected priority vaccines and related biological (sera, Immunoglobulins)

…….So,…Why Immunize?

Immunization & Disease Once your immune system is trained to resist a disease, you are said to be immune to it Before vaccines, the only way to become immune to a disease was to actually get it and…….with luck, survive it You may be contagious and pass the disease to family members, friends, or others who come into contact with you Diseases have been able to circumvent drugs through development of resistance but this is yet to be reported for vaccination Vaccine Efficacy in individuals and population effectiveness differ- basis for prevention programs

……..Measles Rubella Vaccine Introduction

Measles & Rubella Highly infectious, humans are the only reservoir In 2000, measles was leading cause of vaccine preventable pediatric deaths, now 3rd after Pneumococcal and Rotavirus Rubella is a leading cause of congenital defects, 100,000 cases in developing countries annually (Year 2000) Primary objective of rubella vaccination is to prevent this Deaths and Disabilities from Measles and Rubella are completely preventable

Measles- Rubella Introduction & SIAs, Rationale 95% population immunity not achievable with only 1 dose (routine) even at very high vaccination coverage Only 85% of children vaccinated against measles develop immunity from the first dose Accumulation of susceptible children occurs over time (i.e. children with no immunity) High risk of outbreak when number of susceptible ≥ annual birth cohort Second opportunity for vaccination against measles needed to achieve & sustain high population immunity Need to conduct wide age range SIAs prior to Introduction of Rubella vaccine to reduce Risk of paradoxical increase in CRS Cases

1,468,268 1,015,140 523,195 Measles Cov. 1,082,420 (75%) 1,129,057 (78%) 1,178,281 (81%) Un-vaccinated 360,832 (25%) 322,587 (22%) 276,386 (19%) Non Immune 162,363 169,358 176,742

Vaccination status of confirmed cases of measles by year

Distribution of measles and Rubella Cases in Kenya, 2011- 2015 2012 2013 2014 2015

Number of Measles and Rubella Cases

Measles & Rubella control strategies Strengthening routine immunization (RI)- at 9 & 18 months Providing a second opportunity for vaccination with measles vaccine: Supplemental immunization (catch up and follow up) Introduction of second dose of measles vaccine in RI Strengthening of case-based measles surveillance Strengthening of measles Case Management (including Vita A supplementation)

Next for Measles Rubella?, Kenya MR SIAs planned for 16th to 24th May 2016, target 18.9 million children 9months – 14 years Plans to introduce Measles Rubella vaccine into Routine immunization (January 2017) after SIAs Plans to integrate with Tetanus Toxoid sNIDs (in 24 high risk sub- counties) Logistics Required: 21.8 million doses of MR vaccine, 23.5 million syringes 42,000 health workers and 24,000 Volunteers 20,000 vaccination centers, 2,100 vehicles

Immunization Key issues,……. The Country spends approx. 4 Billion Annually to deliver Immunization services It is also much cheaper to prevent a disease than to treat it, Vaccines protect not only yourself but also others around you If a critical number of people within a community are vaccinated against a particular illness, the entire community is less likely to get the disease- herd immunity Vaccination has greatly reduced the burden of infectious diseases, Only clean water, also considered to be a basic human right, performs better

Immunization Key Issues,……. Understandably,…..vaccine safety gets more public attention than vaccination effectiveness,…..but vaccines are far safer than therapeutic medicines Did Jenner have it easy compelling people to comply? Most of the time the games played are according to rules that are not generally those of science The number of deaths & disabilities caused by traditional vaccine-preventable has Reduced dramatically over the years

Key issues…Considerations in introducing Immunization Interventions Is the magnitude of public health problem conclusively determined? Are the risk groups clearly identified? Ensured availability of an effective vaccine? Ability of vaccination services to cover > 80% of at-risk-population in order to break transmission Political Goodwill Cost Implications/ Cost effectiveness 20

Immunization is all our responsibility A world free of Vaccine preventable diseases means NO child gets paralysed, BETTER quality of life, COST SAVINGS on resources spent on rehabilitation, treatment & time from work, and MORE resources available for other priority health needs Immunization is all our responsibility EVERY CHILD COUNTS!

Thank you